Fundz

Myrtelle Llc reported raising $13.5 Million in an initial SEC Form D filing, from an offering of $20.5 Million

PRIVATEJun 24, 2021$13.5M of $20.5M raised

Amount Raised

$13.5 Million

$13.5 Million sold, per SEC Form D (first sale Jun 24, 2021)

Round Type

Venture

New YorkBiotechnology

Quick answer

Myrtelle raised $13.5 Million in a funding round, dated June 24, 2021. Myrtelle is based in New York, New York, United States.

How much did Myrtelle raise?
Myrtelle raised $13.5 Million in a funding round on June 24, 2021.
What does Myrtelle do?
Myrtelle Inc. is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases.
Where is Myrtelle based and how big is it?
Myrtelle is based in New York, New York, United States. Fundz records about 13 employees.
Who are the decision-makers at Myrtelle?
Fundz holds 3 contacts at Myrtelle, including the co-Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Myrtelle that raised within 45 days of this round, from Fundz verified event records.

  • CytoImmune Therapeutics, Inc. raised $37M on August 6, 2021.
  • Lanier Biotherapeutics raised $805K (Seed) on August 6, 2021.
  • Singletto raised $50K on August 6, 2021.
  • CHONEX raised $5.8M on August 6, 2021.
  • Reimagine Care raised $5.3M on August 6, 2021.
  • Unravel Biosciences, Inc. raised $500K (Seed) on August 6, 2021.

Who to call at Myrtelle, and when

A new round usually means Myrtelle is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Myrtelle raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Myrtelle, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Myrtelle. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Myrtelle

Location

17 State Street

New York, New York, United States

About

Myrtelle Inc. is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with our lead program, gene therapy treatment for Canavan disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Myrtelle raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsOlga F., co-Chief Medical OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Myrtelle's next move

See what Strategic adds

Myrtelle raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.